System for generating high concentration factors for low cell density suspensions

Patent metadata

Field	Value
Publication number	US-9745569-B2
Application number	US-201715417181-A
Country	US
Kind code	B2
Filing date	Jan 26, 2017
Priority date	Sep 13, 2013
Publication date	Aug 29, 2017
Grant date	Aug 29, 2017

Abstract

Acoustophoretic devices and methods for concentrating targeted biological cells in a reduced volume using multi-dimensional acoustic standing waves are disclosed. The methods include flowing a mixture of a host fluid and the biological cells through an acoustophoretic device. The acoustophoretic devices include an inlet, an outlet, and a flow chamber having an ultrasonic transducer-reflector pair. Biological cells, such as T cells, are separated from a host fluid for utilization in allergenic or autologous cell therapies. The disclosed devices and methods are capable of concentrating biological cells to at least 100 times their original cell concentration. The disclosed methods and devices are further capable of decreasing an original feed volume to a final concentrated volume that is less than one percent of the original feed volume.

First claim

The invention claimed is:

1. A method for concentrating target cells that include an original cell concentration in a host fluid, comprising:
flowing a mixture of the host fluid and the target cells through an acoustophoretic device, the acoustophoretic device comprising:
a flow chamber including at least one inlet and at least one outlet;
at least one ultrasonic transducer coupled to the flow chamber, the at least one ultrasonic transducer including a piezoelectric material configured to be driven to create a multi-dimensional acoustic standing wave in the flow chamber; and
a reflector on the opposite side of the flow chamber from the at least one ultrasonic transducer; and

driving the at least one ultrasonic transducer to create the multi-dimensional acoustic standing wave in the flow chamber to concentrate the target cells;
wherein the target cells are concentrated to a final concentration of at least 100 times the original cell concentration.

2. The method of claim 1 , wherein the target cells are concentrated to a final concentration of about 150 times to about 300 times the original cell concentration.

3. The method of claim 1 , wherein the target cells are concentrated to a final concentration of about 300 times to about 600 times the original cell concentration.

4. The method of claim 1 , wherein the target cells include an original cell concentration of about 1 million cells per mL.

5. The method of claim 1 , further comprising recovering the target cells in a final concentrated volume from the flow chamber.

6. The method of claim 5 , wherein the total cell retention in the final concentrated volume is at least 80%.

7. The method of claim 1 , wherein the acoustophoretic device is vertically oriented, such that the mixture flows vertically upwards from the at least one inlet toward the at least one outlet.

8. The method of claim 1 , wherein the at least one inlet of the acoustophoretic device is located at a first end of the acoustophoretic device; and
wherein the at least one outlet of the acoustophoretic device includes (i) a permeate outlet located at a second end of the device opposite the first end; and (ii) a concentrate outlet located between the at least one inlet and the at least one ultrasonic transducer, for recovering the target cells.

9. The method of claim 8 , wherein the acoustophoretic device further comprises a collector located between the at least one inlet and the at least one ultrasonic transducer, the collector including at least one angled wall that tapers downwards in cross-sectional area, the collector being fluidly connected to the concentrate outlet.

10. The method of claim 9 , wherein the mixture entering the device through the at least one inlet flow through an annular plenum around the collector.

11. The method of claim 9 , wherein the concentrate outlet is located on a first side of the device.

12. The method of claim 9 , wherein the multi-dimensional acoustic standing wave continuously traps the target cells, such that the target cells agglomerate, aggregate, clump, or coalesce together, and subsequently settle out of the host fluid and into the collector due to enhanced gravitational forces.

13. The method of claim 1 , wherein the at least one inlet is located on a first side of the device such that the mixture turns prior to flowing through the flow chamber.

14. The method of claim 1 , wherein the at least one ultrasonic transducer of the acoustophoretic device is a plurality of ultrasonic transducers arranged serially between the at least one inlet and the at least one outlet of the acoustophoretic device.

15. The method of claim 1 , wherein the target cells are T cells, B cells, or NK cells.

16. The method of claim 1 , wherein the turbidity of the host fluid is reduced by at least 65% after 60 minutes, or at least 70% after 60 minutes, or at least 80% after 60 minutes, or at least 90% after 60 minutes.

17. A method for obtaining concentrated target cells, comprising:
flowing an original feed volume of a mixture of a host fluid and the target cells through an acoustophoretic device, the acoustophoretic device comprising:
a flow chamber including at least one inlet and at least one outlet;
at least one ultrasonic transducer coupled to the flow chamber, the at least one ultrasonic transducer including a piezoelectric material configured to be driven to create a multi-dimensional acoustic standing wave in the flow chamber; and
a reflector opposite to the at least one ultrasonic transducer; and

driving the at least one ultrasonic transducer to create the multi-dimensional acoustic standing wave, which continuously traps and concentrates the target cells; and
recovering at least 40% the concentrated target cells in the original feed volume in a final concentrated volume, wherein the final concentrated volume is at least 100 times smaller than the original feed volume.

18. An acoustophoretic device for concentrating biological cells, comprising:
at least one inlet at a first end of the device;
a concentrate outlet on a first side of the device;
a flow chamber fluidly connected to the at least one inlet and the concentrate outlet;
at least one ultrasonic transducer coupled to the flow chamber, the at least one ultrasonic transducer including a piezoelectric material configured to be driven to create a multi-dimensional acoustic standing wave in the flow chamber; and
a collector located between the at least one inlet and the at least one ultrasonic transducer, the collector including at least one angled wall that tapers downwards in cross-sectional area, the collector being fluidly connected to the concentrate outlet.

19. The device of claim 18 , wherein the at least one inlet of the acoustophoretic device is located at a first end of the acoustophoretic device; and wherein the device further comprises a permeate outlet located at a second end of the device opposite the first end.

20. The device of claim 18 , including an annular plenum around the collector fluidly connecting the at least one inlet to the flow chamber.

Assignees

• Flodesign Sonics Inc

Inventors

• Lipkens Bart
• Dionne Jason
• Ghoshal Goutam

Classifications

• G10K15/043

  producing shock waves (G10K15/046, G10K15/06 take precedence; generating seismic energy G01V1/02) · CPC title

• C12M47/02

  Separating microorganisms from the culture medium; Concentration of biomass (separating microorganisms from their culture media C12N1/02) · CPC title

• C12N13/00 Primary

  Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

• H10N30/2023

  having polygonal or rectangular shape · CPC title

• H10N30/8554

  Lead-zirconium titanate [PZT] based · CPC title